| 영문 | connective tissue | 한글 | 결합조직 |
|---|---|---|---|
| 설명 | 체내에 널리 분포하며, 장기, 조직사이를 메우고 그것을 기계적으로 지지, 조직이다. 그밖에 혈관, 림프관, 신경을 인도하며 영양, 대사산물의 수송 또는 저류, 나아가서는 손상, 감염에 대한 방어 또는 수복 등에도 작용한다. 결합조직은 세포간질이 풍부하며, 세포간질을 구성하는 기질과 섬유의 성상에 따라 간엽조직, 섬유성 결합조직(성긴섬유성 결합조직, 촘촘한 섬유성 결합조직), 지방조직, 탄성조직, 세망 조직 등으로 분류된다. |
||
| 영문 | osseous tissue | 한글 | 뼈조직, 골조직 |
|---|---|---|---|
| 설명 | 골세포와 골세포주위의 딱딱한 칼슘조직으로 둘러싸인 밀집된 결합조직을 뜻한다. 이 골조직에 의해서 뼈가 이루어져 인체의 골격을 형성한다. |
||
| 영문 | epithelial tissue | 한글 | 상피조직 |
|---|---|---|---|
| 설명 | 상피는 한 층 또는 여러 층의 세포로 이루어진 판 모양의 구조로 신체의 표면과 관상구조의 내강을 둘러싸고 있다. 상피세포와 상피세포사이의 적은 양으로 존재하여 상피사이의 공간을 채우고 있는 세포간질을 합쳐 상피조직이라 한다. 상피조직에는 원칙적으로 혈관이 분포되어 있지 않다. |
||
| 영문 | granulation tissue | 한글 | 육아조직 |
|---|---|---|---|
| 설명 | 모세혈관이 풍부하며 왕성하게 증식을 계속하는 어린 결합조직. 창상 등 조직 결손에 대한 수복, 이물처리의 기질화, 염증이 만성적인 경과에 있거나 종양증식에 동반된 사이물질의 반응성 염증에서 관찰된다. 구성성분은 생긴지 얼마 안되는 어린 육아조직은 섬유모세포의 증식, 새로 생긴 모세혈관과 여러 유주세포 및 다른 중간엽세포(백혈구, 림프구, 형질세포, 조직구, 단핵구, 거대세포)등으로 구성된다. 이것이 시간이 지나 그리되면, 모세혈관과 유주세로, 다른조직성분을 감소시켜 만성화하여 오래된 육아가 되며 결국은 섬유세포와 아교질섬유로 구성된 반흔조직으로 변한다. |
||
| 영문 | tissue | 한글 | 조직 |
|---|---|---|---|
| 설명 | 특정 구조와 기능을 갖는 세포 집단. 세포 사이에는 다소간 세포간질이 들어 있다. 세포간질에는 글리코사미노글리칸, 히드록시아파타이트와 같은 기질과 아교질섬유와 같은 섬유가 발견된다. 조직성상은 구성세포와 세포간질의 종류와 양에 의해 결정된다. 조직은 상피조직, 지지조직, 근육조직, 신경조직으로 대별되며, 상피조직은 세포간질을 거의 갖지 않으며, 지지조직은 결합조직이나 뼈조직과 같이 세포간질이 풍부한 것이 많다. |
||
| ABCDES | abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi... |
|---|---|
| TCID | tissue culture infective dose; tissue culture inoculated dose |
| TCID50 | median tissue culture infective dose; 50% tissue culture infective dose |
| ICA | 1) Islet Cell Antibody 2) Internal Carotid Artery |
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
| IAPP | Islet amyloid polypeptide |
|---|---|
| ICA | Islet Cell-Cytoplasmic Antibodies |
| IAP | Islet activating protein |
| ICA | Islet cell |
| ICA | Islet cell antibodies |
acute angle
| islet tissue | <anatomy> Groups of cells found within the pancreas: A cells and B-cells secrete insulin and glucagon. See: D cells. (18 Nov 1997) |
|---|
| adenoma, islet cell | A benign tumour of the islets of langerhans that may occur anywhere throughout the pancreas. Such tumours may result in hyperinsulinism or zollinger-ellison syndrome. (12 Dec 1998) |
|---|---|
| blood islet | An aggregation of splanchnic mesodermal cells on the embryonic yolk sac, with the potentiality of forming vascular endothelium and primitive blood cells. Synonym: blood islet. (05 Mar 2000) |
| carcinoma, islet cell | A carcinoma of the islets of langerhans. (12 Dec 1998) |
| pancreatic isleT-cell tumours | <radiology> Insulinoma (beta-cell), usually solitary, 85% benign, gastrinoma, small, slow-growing, multiple, 60% malignant, Zollinger-Ellison syndrome: mult. Intractable ulcers, VIPoma, vasoactive intestinal peptide (VIP), WDHA syndrome: watery diarrhoea, hypokalaemia, achlorhydria, Verner-Morrison syndrome, glucagonoma, hyperglycaemia, migratory necrolytic erythema APUDomas, associated with MEN-1 (12 Dec 1998) |
| islet | A small island. (05 Mar 2000) |
| islet amyloid peptide | <hormone, protein> Peptide of 37 amino acids that selectively inhibits insulin stimulated glucose uptake in muscle. Structurally related to calcitonin gene-related peptide. (15 Oct 1997) |
| islet cell | <pathology> Cells of the Islets of Langerhans within the pancreas. See: A cells, B-cells, D cells. (18 Nov 1997) |
| islet cell adenoma | <tumour> A benign neoplasm of the pancreas composed of tissue similar in structure to that of the islets of Langerhans; it may contain functioning beta cells, and may cause hypoglycaemia. See: insulinoma. Synonym: nesidioblastoma. (05 Mar 2000) |
| islet cell antibodies | In first-degree relatives of probands with insulin-dependent diabetes mellitus the presence of high titre ICA of the IgG cytoplasmic variety (IgG -ICA) and ICA of the complement-fixing subgroup (CF-ICA) confer a relative risk of 75 for development of insulin-dependent diabetes mellitus. The presence of ICA combined with a decrease in the first-phase of insulin secretion ( less than 25 micro U/mL) is predictive with a 95% likelihood of the development of insulin-dependent diabetes mellitus within 12 months. Reproducible results among laboratories are possible with careful attention to selection of the human pancreas as substrate as well as to the use of dilutions to generate standard curves and to the conversion of results to units. The prozone phenomena described elsewhere are not common in our experience. Fifty percent of relatives with a single positive ICA test will develop insulin-dependent diabetes mellitus within 10 years, and 60-80% of relatives with both ICA and insulin autoantibodies (IAA) will develop insulin-dependent diabetes mellitus within 10 years. The predictive value for health of negative results for ICA and IAA is almost 99%. Strong, persistently positive ICA (i.e., 40 JDF U or greater), especially if accompanied by markedly decreased insulin secretion, are the best predictors of subsequent development of insulin-dependent diabetes mellitus. The 64 kD beta-cell autoantigen long thought to be an important target for ICA is not yet available from expression cloning despite efforts by several groups.13 ICA positivity correlates with rapid loss of C-peptide secretory capacity in newly diagnosed ICA-positive insulin-dependent diabetes mellitus. The predictive values of ICA for development of insulin-dependent diabetes mellitus within 10 years in first-degree relatives of patients with insulin-dependent diabetes mellitus increase from 40% at low levels of ICA to 100% at high levels, whereas the sensitivity is 88% at low levels and 31% at high levels. In general, the risk of insulin-dependent diabetes mellitus in relatives of probands increases with titre of ICA, is greater in multiplex families, and is increased in those less than 10 years of age with positive ICA. Although the prevalence of ICA in Japanese with autoimmune thyroid disease resembles that in Caucasians, the incidence of insulin-dependent diabetes mellitus in the Japanese population is only 1/30 - 1/50 that in Caucasians. Prediabetics positive for ICA and IAA have increased suppressor-inducer (CD45R) and decreased helper-inducer (CDw29) peripheral blood lymphocytes. In two randomised, prospective, placebo-controlled studies of recent-onset insulin-dependent diabetes mellitus, cyclosporine immunosuppression increased the rate of non-insulin-requiring remissions as well as beta-cell function during drug treatment. Although 12 months of cyclosporine therapy decreases titres of ICA and insulin antibodies (IA) and increases glucagon-stimulated levels of serum C-peptide, the determination of ICA and IA and HLA-DR type are of no predictive value in selecting recent- onset insulin-dependent diabetes mellitus. Patients for cyclosporine immunointervention. Genetic control of autoimmunity in insulin-dependent diabetes mellitus is reviewed. EIA for autoantibodies to a 64 kD islet-cell protein is promising for prediction of insulin-dependent diabetes mellitus, but sensitivity and specificity are still suboptimal. See also: insulin antibodies. (05 Mar 2000) |
| islet cell antigen-related protein-tyrosine phosphatase | <enzyme> Receptor-like autoantigen found in insulin-dependent diabetes; genbank l76258 Registry number: EC 3.1.3.- Synonym: iar ptp (26 Jun 1999) |
| islet-cell-stimulating antibodies | <immunology> Autoantibodies to a putative beta-cell receptor; stimulate the release of insulin both in rodents and man; may be analogous to the thyroid stimulating antibodies that cause grave's hyperthyroidism Synonym: icsta (05 Dec 1998) |
| islet neogenesis-associated protein | <chemical> Constituent of ilotropin; stimulates proliferation of pancreatic ductal cells in vitro; from hamsters and humans; amino acid sequence given in first source Synonym: ingap protein, ingap gene product (05 Dec 1998) |
| adenoid tissue | A structure found within the lymphatic system that consists of lymphocytes within a network of fibres. (09 Oct 1997) |
| adipose tissue | <anatomy> Connective tissue that has been specialised to store fat. See: adipocyte. (25 Jun 1999) |
| aerenchymous tissue | A type of plant tissue in which cells are unusually large, resulting in large air spaces in the plant organ, such tissues are often referred to as spongy and usually provide increased buoyancy. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|